|
March 8, 2010
Flamel Technologies Announces Fourth Quarter and Year-End 2009 Results A conference call to discuss the earnings is scheduled for 8:30 AM EST on March 09, 2010.
The dial-in number (for investors in the U.S. and Canada) is 1-877-857-6173; the conference ID number is 2453008.
International investors are invited to dial 1 719-325-4888.
Webcast
March 1, 2010
Flamel Technologies Announces Projected Release Date of Fourth Quarter and Annual Results; Conference Call
December 18, 2009
Flamel Technologies Announces the Initiation of a Phase 2a Clinical Trial of Flamel's IFN-Alpha-2b XL
in Patients with Chronic Hepatitis C Virus Infection
November 16, 2009
Flamel Technologies Announces Third Quarter 2009 Results; Additional
New Projects; Cash Increases from $45.1 to $48.8 million
A conference call to discuss earnings is scheduled for 8:30 AM EST November 16, 2009.
The dial-in number (for investors in the U.S. and Canada) is 1-800-860-2442; the conference ID number is 435349.
International investors are invited to dial 1 412-858-4600. Webcast
November 04, 2009
Flamel Technologies Announces Licensing Agreement with Pfizer
September 18, 2009
Flamel Technologies to Present at UBS Global Life Sciences Conference
|